How a brain implant and AI can help a paralysed person speak and sing short melodies
How does this work? The interface uses electrodes, either implanted directly on the brain's surface or placed on the scalp, which decode electrical activity in the brain related to speech. It interprets signals associated with attempted or imagined speech, then translates them into usable outputs like text or synthesized speech in real time via a computer. The latest study, on how this technology helped a man 'speak' flexibly and expressively through a computer, was published recently in the scientific journal, Nature.
'The brain-computer interface described in this study is the first-of-its-kind as it translates brain activity directly into expressive voice within milliseconds, giving the participant full control over not only what they speak but also how they speak. This has not been achieved before,' says first author Maitreyee Wairagkar, who is a project scientist at the UC Davis Neuroprosthetics Lab.
Why this new module is practical
Assistive communication devices such as eye-trackers and speller boards that are currently available to people with speech loss are slow and tedious to use. 'A brain-computer interface offers a potential solution to restore communication by bypassing the damaged pathways of the nervous system and directly intercepting this information from the brain,' say researchers.
How the next generation of brain-computer interface can reconstruct voice
According to Wairagkar, previous BCI studies deciphered brain activity and vocalised them into words on the computer. 'But speech is more than just words – not only what we say but also how we say it determines the meaning of what we want to convey. We change our intonation to express different emotions – all these nuanced aspects of speech are not captured by text-based communication technologies. Moreover communication via text is slow whereas our speech is fast and allows real-time conversations. The next generation brain-computer interface can modulate and even 'sing' short simple melodies,' says Wairagkar.
On the scope of study
The study was conducted on a patient of Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease. It is a neurodegenerative disease that gradually weakens the muscles and leads to paralysis. So patients are unable to move or speak. Their cognition or the ability to process the world around them, however, remains intact throughout the disease, which means that even if they want to speak or move, they are unable to do so due to the paralysis caused by ALS.
In this trial, four microelectrode arrays (devices containing multiple microscopic electrodes, in this case 256) were surgically placed in the area of the ALS patient's brain that controls the movement of his vocal tract, which in turn enables speech. Researchers then developed a brain-computer interface that translated his brain activity directly into voice, using artificial intelligence algorithms. It enabled him to speak expressively through a computer in real-time.
To train the artificial intelligence algorithms, researchers first asked the participant to speak the sentences displayed on the screen, so that they knew what he was trying to say. 'Then we trained these algorithms to map the brain activity patterns to the sounds he was trying to make with each word,' Wairagkar explains.
What next?
Although the findings are promising, the study was done with a single clinical trial participant. It will now have to be expanded to other patients, including those who have speech loss from other causes such as stroke, to see if this result is being replicated.
'We want to improve the intelligibility of the system such that it can be used reliably for day-to-day conversations. This could be achieved through developing more advanced artificial intelligence algorithms to decode brain activity, recording higher quality neural signals and improved brain implants,' says Dr Wairagkar.
Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition.
... Read More
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Laser-free vision correction uses electrical current to reshape eye
Washington: Researchers have developed a potential alternative to LASIK surgery that corrects vision without the use of lasers. The new method, called electromechanical reshaping (EMR) , uses electrical currents and a platinum contact lens to alter the shape of the cornea. The technique was presented during a meeting of the American Chemical Society by a team led by Michael Hill, professor of chemistry at Occidental College. EMR relies on generating pH changes in collagen-containing tissues such as the cornea, making them temporarily malleable. In experiments involving rabbits, the team used a platinum "contact lens" in the shape of a corrected cornea as a way to generate precise pH changes in the animal's tissues. Roughly a minute later, around the time it takes to perform LASIK, the rabbit's cornea conformed to the contact lens -- but with fewer steps and no incisions, according to the researchers. The team successfully improved the shape of eyeballs, which were treated as if they had myopia, or nearsightedness, in ten out of 12 rabbit eyeballs. According to the team, EMR could address conditions such as myopia and may also treat chemical-induced cloudiness, which usually requires a corneal transplant. Brian Wong, professor at the University of California, Irvine, said the effect was discovered by accident while studying tissue modification. Hill noted that further detailed animal studies will be required before any clinical use, but added that the approach could prove more affordable and potentially reversible compared with current methods. "There's a long road between what we've done and the clinic," said Hill in the statement. "But, if we get there, this technique is widely applicable, vastly cheaper and potentially even reversible."
Time of India
17 hours ago
- Time of India
Dormant Cancer: COVID, flu viruses can awaken dormant cancer cells, finds US study: Know what it means and how serious it is
Scientists at the University of Colorado set out to crack the mystery of why some cancer survivors suddenly face their cancer coming back (metastasis), sometimes years after treatment. Tired of too many ads? go ad free now The culprit, it turns out, might be infections from respiratory viruses like influenza and SARS-CoV-2 (the virus that causes COVID-19). These common bugs, which most of us get at least occasionally, can spark inflammation throughout the body. And for dormant cancer cells—called disseminated cancer cells or DCCs—this inflammation is a loud wake-up call. Here's what they did: Researchers used mouse models of breast cancer to see how infections affected these sleeping cancer cells. They infected the mice with either influenza or SARS-CoV-2. What happened next was jaw-dropping: Within just three days, the number of DCCs in the lungs shot up. Not only that, these cells were way more likely to 'wake up' and grow. In fact, the number remained high for months after infection. So, those cancer cells that had almost disappeared quietly multiplied again, due to the infection. The findings of the study have been published in Nature journal. Digging deeper, the team found a key player: an inflammatory molecule called IL-6. Mice that couldn't make IL-6 didn't see the same explosion of DCCs after infection. This means IL-6 acts like a middleman, triggering dormant cancer cells to get back into action. Even the immune system wasn't off the hook. They spotted that CD4+ T cells—a type of immune cell—were actually helping these newly active cancer cells by holding back another part of the immune system, the CD8+ T cells, which would normally hunt and destroy cancer cells. Tired of too many ads? go ad free now When researchers zapped the CD4+ T cells, more CD8+ T cells got to work and wiped out more cancer. But that's mice. What about people? The researchers checked large health record databases in the UK, looking at people who had been in cancer remission. Those who got COVID-19 had nearly double the risk of dying from cancer than those who didn't get the virus. In another large group of women with breast cancer, getting COVID increased the risk of the cancer spreading to the lungs by about 40%. That's a serious bump. So, what does it mean for cancer survivors? This study suggests that respiratory viruses—including those we might take for granted—could play a hidden role in cancer coming back, especially in the lungs. It doesn't mean every cold or bout of flu will trigger a problem, but for people who've beaten cancer once, it's one more reason to take infections seriously and consider preventive steps when possible. Doctors and scientists are now on the lookout for ways to block this process—perhaps by targeting that IL-6 molecule or tweaking the immune response—to help keep those cancer 'embers' from getting fanned into flames again. If you're a cancer survivor, staying up to date with vaccinations, practicing good hygiene, and talking to your doctor about risk during cold, flu, and COVID seasons could be even more important than you realized. It's not just about dodging a tough week in bed—it's about keeping those lurking cancer cells asleep, for good.
Hindustan Times
2 days ago
- Hindustan Times
Seeing Silicon: A bot to tackle blood clots
When I first saw a demo of the milli-spinner in Stanford Robotics Center, it reminded me of a 1966 film Fantastic Voyage in which a submarine crew is shrunk to microscopic size and ventures into the body of an injured scientist to repair the damage to his brain. Except scientists at the Stanford University imagined a more efficient way of dispensing targeted drug inside a human body – a worm-sized robot that can travel through veins and compress a blood clot, treating strokes and heart attacks. The milli-spinner prototype takes up a small display in the medical robotics room. What looms in the room when I enter are larger robots used for imaging and surgery. The millirobot in comparison is less than one centimeter in size. It moves like a tiny worm inside a web of transparent tubes, controlled by a magnetic field. The hollow tube, barely visible unless you bend closer and have a look, rotates rapidly using a series of slits. It was this movement that took mechanical engineer Dr Renee Zhao, the head of the lab and the creator of the robot, years to master. The movement made all the difference. 'With existing technology, there was no way to reduce the size of a blood clot. They relied on deforming and rupturing the clot to remove it,' explains Dr Zhao, assistant professor of mechanical engineering. Once they got the spinning right, the milli-spinner could enter the body through a catheter, draw the clot and compress it before suctioning it out. In a recent scientific paper published in Nature in June 2025, Dr Zhao and her team showed that this new approach to technology – compression before suction - outperformed available treatments in removal of clots from human bloodstream. 'At first, we simply wondered whether this suction could help remove a blood clot,' Zhao said. 'But when we tested the spinner on a clot, we observed a dramatic reduction in volume. Honestly, it felt like magic.' Also Read: Seeing Silicon | Is this year the beginning of the end of smartphones? The more I see and read about the upcoming technologies in medical devices, the more magical it does feel. Stanford's not the first one to develop millirobots, though Zhao has a lot of experience working on millirobots. After the microelectronic advances in the early 2000s, microfabrication allowed engineers to create intricate mechanical and electronic components on a microscopic scale. Due to their small size, microrobots (about one centimetre) and millirobots (less than one centimetre) could be made cheap and could be used in large numbers – like in swarm robotics. However, there was one challenge, and it took technologists another decade to solve it. How do you make these millirobots move through the body without them being tethered to a power source? The microrobots came with small lightweight battery sources but it wasn't enough for them to navigate inside blood vessels or reach hard to reach places. (Just like Fantastic Voyage shows, our blood vessels are complicated rivers to navigate). It was with Wi-Fi, another technology that has dramatically changed our lives, that scientists finally figured out how to control the device inside the body. This level of control meant that these millirobots could become quite useful to deliver precision medicine inside the human body. They could also be used to minimally invasive surgery, diagnostics or navigating blood vessels for treatment. The last decade has seen a flurry of experiments in medical millirobots, the Stanford experiment being one of the latest successful examples of the technology. Some of them have already made it to our hospitals and treatment. For example, biohybrid microswimmers which are created using bacteria, microalgae have been used for advanced medical functions – like targeted therapy of tumours. But most innovations are still in laboratories of research institutions. The next level to these kinds of robots is xenobots, the world's first living robots – built from the heart muscle and stem cells harvested from an early African frog embryo. These AI-designed robots are less than 1 millimetre wide, can simulate a specific task and can work in swarms. They use energy from fat and protein naturally stored in their tissue, which lasts about a week at which point they simply turn into dead skin cells. Future possible uses are treating individuals by creating xenobots using their own cells (reducing the immune response challenge with bots inside your body) and even to aggregate tiny bits of ocean-polluting microplastics into a large ball of plastic to recycle. The latest biorobotics does feel like magic rather than technology, just as Dr Zhao felt when she saw the milli-spinner compress the blood clot. More and more, the technological advances in biomedicine do sound like alchemy to me. Shweta Taneja is an author and journalist based in the Bay Area. Her fortnightly column will reflect on how emerging tech and science are reshaping society in Silicon Valley and beyond. Find her online with @shwetawrites. The views expressed are personal.
